Efficient Gene Silencing by Adenine Base Editor-Mediated Start Codon Mutation
Overview
Pharmacology
Authors
Affiliations
Traditional CRISPR/Cas9-based gene knockouts are generated by introducing DNA double-strand breaks (DSBs), but this may cause excessive DNA damage or cell death. CRISPR-based cytosine base editors (CBEs) and adenine base editors (ABEs) can facilitate C-to-T or A-to-G exchanges, respectively, without DSBs. CBEs have been employed in a gene knockout strategy: CRISPR-STOP or i-STOP changes single nucleotides to induce in-frame stop codons. However, this strategy is not applicable for some genes, and the unwanted mutations in CBE systems have recently been reported to be surprisingly significant. As a variant, the ABE systems mediate precise editing and have only rare unwanted mutations. In this study, we implemented a new strategy to induce gene silencing (i-Silence) with an ABE-mediated start codon mutation from ATG to GTG or ACG. Using both in vitro and in vivo model systems, we showed that the i-Silence approach is efficient and precise for producing a gene knockout. In addition, the i-Silence strategy can be employed to analyze ~17,804 human genes and can be used to mimic 147 kinds of pathogenic diseases caused by start codon mutations. Altogether, compared to other methods, the ABE-based i-Silence method is a safer gene knockout strategy, and it has promising application potential.
gene mutation through CRISPR RNA-guided base editing weakens bacterial virulence and immune evasion.
Liu X, Huang L, Ye Y, Wang H, Tang M, He F Virulence. 2025; 16(1):2451163.
PMID: 39843407 PMC: 11759621. DOI: 10.1080/21505594.2025.2451163.
In vivo base editing extends lifespan of a humanized mouse model of prion disease.
An M, Davis J, Levy J, Serack F, Harvey J, Brauer P Nat Med. 2025; .
PMID: 39810005 DOI: 10.1038/s41591-024-03466-w.
Xu W, Zhang S, Qin H, Yao K J Transl Med. 2024; 22(1):1133.
PMID: 39707395 PMC: 11662623. DOI: 10.1186/s12967-024-05957-3.
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance.
Wellhausen N, Baek J, Gill S, June C Nat Rev Cancer. 2024; 24(9):614-628.
PMID: 39048767 DOI: 10.1038/s41568-024-00723-5.
Comprehensive analysis of the editing window of C-to-T TALE base editors.
Feola M, Pulicani S, Tkach D, Boyne A, Hong R, Mayer L Sci Rep. 2024; 14(1):12870.
PMID: 38834632 PMC: 11150444. DOI: 10.1038/s41598-024-63203-8.